<div id="readability-page-1"><p>In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on Spectral AI, with a price target of <span id="expert-recommendation-target">$6.00</span>.</p><h3>Meet Your ETF AI Analyst</h3><ul><li> Discover how TipRanks' <i>ETF</i> AI Analyst  can help you make smarter investment decisions </li><li>   Explore ETFs TipRanks' users love  and see what insights the <b><i>ETF</i> AI Analyst</b> reveals about the ones you follow.</li></ul> <p>Byrnes covers the Healthcare sector, focusing on stocks such as Brainsway, Alvotech, and BioLife Solutions. According to TipRanks, Byrnes has an average return of <span>-4.1%</span> and a 36.78% success rate on recommended stocks. </p> <p>In a report released today, BTIG also maintained a Buy rating on the stock with a $3.00 price target.</p></div>

MDAI

<p>Northland Securities has maintained a Buy rating on Spectral AI (MDAI) with a price target of $6.00, as reported by Carl Byrnes. Additionally, BTIG also holds a Buy rating for the stock, setting a price target of $3.00. Byrnes focuses on the Healthcare sector and has an average return of -4.1% with a 36.78% success rate on his stock recommendations.</p>

Northland Securities Keeps Their Buy Rating on Spectral AI (MDAI)